FDA Label for Unisom Sleepminis Nighttime Sleep-aid

View Indications, Usage & Precautions

Unisom Sleepminis Nighttime Sleep-aid Product Label

The following document was submitted to the FDA by the labeler of this product Chattem, Inc.. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.

Active Ingredient



(in each mini-capsule)

Diphenhydramine HCI 25 mg


Purpose



Nighttime sleep-aid


Use



  • for relief of occasional sleeplessness

Do Not Use



  • for children under 12 years of age
  • with any other product containing diphenhydramine, even one used on skin

Ask A Doctor Before Use If You Have



  • a breathing problem such as emphysema or chronic bronchitis
  • glaucoma
  • trouble urinating due to an enlarged prostate gland

Ask A Doctor Or Pharmacist Before Use If You Are



taking sedatives or tranquilizers


When Using This Product



  • avoid alcoholic drinks

Stop Use And Ask A Doctor If



  • sleeplessness persist continuously for more than 2 weeks. Insomnia may be a symptom of serious underlying medical illness.

If Pregnant Or Breast-Feeding,



ask a health professional before use.


Keep Out Of Reach Of Children.



In case of overdose, get medical help or contact a Poison Control Center right away.


Directions



  • adults and children 12 years of age and over: 2 mini-capsules (50 mg) at bedtime if needed, or as directed by a doctor

Inactive Ingredients



blue 1, citric acid, gelatin, lactose, polysorbate 80, potassium sorbate, pregelatinized corn starch, red 3, titanium dioxide (309-121)


Principal Display Panel



Unisom
#1 Pharmacist Recommended Ingredient*
SleepMinis
Diphenhydramine HCI
Mini-Capsules, 25 mg
NIGHTTIME SLEEP-AID
20 Mini-Capsules


* Please review the disclaimer below.